Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at ...

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Elevance Health (ELV – Research Report). The ...

Elevance Health saw net income fall 2.9% to $2.2 billion during the first quarter, the insurer announced Tuesday.

They currently have a $478.00 price target on the stock. Several other research analysts have also recently weighed in on the company. Stephens cut Elevance Health from an “overweight” rating ...

A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...

Argus raised shares of Elevance Health from a “hold” rating to a “buy” rating and set a $450.00 target price on the stock in a report on Monday, March 17th. Barclays increased their price ...

This compares to the stock's 8% gain over the past four weeks. Elevance Health’s share price benefited from investors seeking stability amid heightened market volatility. A sharp sell-off in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...